Factores del abuso sexual en la niñez y la adolescencia en estudiantes de Morelos, México

OBJETIVO: Estimar la prevalencia y los factores asociados al abuso sexual en niñez y adolescencia. MÉTODOS: Estudio realizado en una muestra de estudiantes del estado de Morelos, México, en 2004-2005. Los participantes (n=1730) pertenecen a una cohorte de 13.293 estudiantes de 12 a 24 años. Los datos fueron colectados mediante la aplicación de un cuestionario conteniendo secciones de escalas validadas. Las variables analizadas fueron: factores sociodemográficos (sexo, zona de habitación, nivel socioeconómico); familiares (educación de los padres, adicciones de los padres, violencia entre padres); psicológicos individuales (autoestima - Inventario de Autoestima de Coopersmith, depresión, consumo de alcohol); violencia intrafamiliar (Escala de Strauss); y abuso sexual. Mediante regresión logística múltiple se evaluaron los factores asociados. Se obtuvieron Razones de Momios (RM) con intervalos de confianza al 95%. RESULTADOS: El 4.7% (n=80) de los (as) estudiantes presentaron intento de abuso y el 2.9% (n=50) fueron víctimas de abuso sexual consumado. Las mujeres tuvieron mayor prevalencia de intento (6.1%). El 3.6% de las mujeres y el 1.9% de los hombres fueron abusados sexualmente. Principal agresor en mujeres fue el novio y en hombres una persona desconocida. Edad promedio de 12.02 años en mujeres y 11.71 en hombres. Factores asociados al abuso: mayor consumo de alcohol padres (RM = 3.37; IC 95% 1.40;8.07); violencia hacia madre (RM=4.49; IC 95%1.54;13.10); ser mujer (RM = 2.47; IC 95%1.17;5.24); ser víctima de violencia intrafamiliar alta (RM=3.58; IC 95%1.32;9.67). Autoestima alta fue un factor protector (RM=0.27; IC 95% 0.09;0.75). CONCLUSIONES: En promedio el abuso sexual se presenta a los 12 años de edad en ambos sexos, siendo más frecuente en el sexo femenino. La mayoría de víctimas no lo denuncia.

Molecular characterization of Aeromonas spp. and Vibrio cholerae O1 isolated during a diarrhea outbreak

This work aimed to assess pathogenic potential and clonal relatedness of Aeromonas sp. and Vibrio cholerae isolates recovered during a diarrhea outbreak in Brazil. Clinical and environmental isolates were investigated for the presence of known pathogenic genes and clonal relatedness was assessed by intergenic spacer region (ISR) 16S-23S amplification. Four Aeromonas genes (lip, exu, gcat, flaA/B) were found at high overall frequency in both clinical and environmental isolates although the lip gene was specifically absent from selected species. A fifth gene, aerA, was rarely found in A. caviae, the most abundant species. The ISR profile revealed high heterogeneity among the Aeromonas isolates and no correlation with species identification. In contrast, in all the V. cholerae isolates the four genes investigated (ctxA, tcpA, zot and ace) were amplified and revealed homogeneous ISR and RAPD profiles. Although Aeromonas isolates were the major enteric pathogen recovered, their ISR profiles are not compatible with a unique cause for the diarrhea events, while the clonal relationship clearly implicates V. cholerae in those cases from which it was isolated. These results reinforce the need for a better definition of the role of aeromonads in diarrhea and whether they benefit from co-infection with V. cholerae.

Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes

Background: Clinical in-stent restenosis (CISR) is the main limitation of coronary angioplasty with stent implantation. Objective: Describe the clinical and angiographic characteristics of CISR and the outcomes over a minimum follow-up of 12 months after its diagnosis and treatment. Methods: We analyzed in 110 consecutive patients with CISR the clinical presentation, angiographic characteristics, treatment and combined primary outcomes (cardiovascular death, nonfatal acute myocardial infarction [AMI]) and combined secondary (unstable angina with hospitalization, target vessel revascularization and target lesion revascularization) during a minimal follow-up of one year. Results: Mean age was 61 ± 11 years (68.2% males). Clinical presentations included acute coronary syndrome (ACS) in 62.7% and proliferative ISR in 34.5%. CISR was treated with implantation of drug-eluting stents (DES) in 36.4%, Bare Metal Stent (BMS) in 23.6%, myocardial revascularization surgery in 18.2%, balloon angioplasty in 15.5% and clinical treatment in 6.4%. During a median follow-up of 19.7 months, the primary outcome occurred in 18 patients, including 6 (5.5%) deaths and 13 (11.8%) AMI events. Twenty-four patients presented a secondary outcome. Predictors of the primary outcome were CISR with DES (HR = 4.36 [1.44–12.85]; p = 0.009) and clinical treatment for CISR (HR = 10.66 [2.53–44.87]; p = 0.001). Treatment of CISR with BMS (HR = 4.08 [1.75–9.48]; p = 0.001) and clinical therapy (HR = 6.29 [1.35–29.38]; p = 0.019) emerged as predictors of a secondary outcome. Conclusion: Patients with CISR present in most cases with ACS and with a high frequency of adverse events during a medium-term follow-up.

Induction of systemic resistance in tomato by the autochthonous phylloplane resident Bacillus cereus

The objective of this work was to verify if the induced resistance mechanism is responsible for the capacity of a phylloplane resident bacteria (Bacillus cereus), isolated from healthy tomato plants, to control several diseases of this crop. A strain of Pseudomonas syringae pv. tomato was used as the challenging pathogen. The absence of direct antibiosis of the antagonist against the pathogen, the significant increase in peroxidases activity in tomato plants exposed to the antagonist and then inoculated with the challenging pathogen, as well as the character of the protection, are evidences wich suggest that biocontrol efficiency presented by the antagonist in previous works might be due to induced systemic resistance (ISR).

Actividad insecticida sobre Spodoptera frugiperda (Lepidóptera: Noctuidae) de los compuestos aislados de la parte aérea de Piper septuplinervium (Miq.) c. dc. y las inflorescencias de Piper subtomentosum Trel. & Yunck. (Piperaceae)

The bioassay-guided purification of ethanolic extracts from inflorescences of Piper subtomentosum Trel. & Yunck and aerial part of Piper septuplinervium (Miq. ) C. DC. led to isolation of five flavonoids, uvangoletin (1), galangin (2), chrysin (5), 5-hydroxy-4',7-dimethoxy-flavone (6), pinostrobin (7); one amide, N-p-coumaroil-tyramine (4); one acylglycerol, monopalmitin (3); one derivative of acid, protocatechuic acid (8); and glycosydated sterol, daucosterol (9). Their structures were elucidated on the basis of spectroscopy and spectrometry data and by comparison with data reported in the literature. The isolated compounds were tested against Spodoptera frugiperda. The results showed galangin and protocatechuic acid to be the most active (LC 50 13.63 and 17.16 ppm, respectively).

Alterações metabólicas em plantas de feijão originadas de sementes microbiolizadas por Pseudomonas sp. e inoculadas com Xanthomonas axonopodis pv. phaseoli

Muitas enzimas estão envolvidas em reações de defesa de plantas contra patógenos. O objetivo deste trabalho foi verificar alterações na atividade de algumas destas enzimas em plantas de feijão originadas de sementes microbiolizadas com um isolado de Pseudomonas do grupo das fluorescentes (isolado DFs842). Sementes de feijão cultivar BRS Valente foram imersas em suspensão salina preparada a partir de crescimento bacteriano com 24 h do isolado de Pseudomonas (OD540=0,5) sabidamente biocontroladora de Xanthomonas axonopodis pv. phaseoli. Como testemunhas, as sementes foram imersas em solução salina (NaCl 0,85%). Após a microbiolização por 5 h a 10ºC, as sementes foram plantadas em vasos contendo uma mistura de solo não esterilizado, areia e esterco bovino (proporção 3:1:1), mantidos em casa de vegetação. A inoculação do patógeno foi realizada na terceira folha verdadeira de todas as plantas, fazendo-se cortes com tesoura imersa em suspensão salina do patógeno (X. axonopodis pv. phaseoli) preparada a partir de crescimento de 24 h (OD540=0,4). Câmaras úmidas foram mantidas 24 h antes e após a inoculação. Para o preparo do extrato protéico, as três primeiras folhas verdadeiras foram coletadas individualmente em 5 épocas de coleta distintas: uma, momentos antes da inoculação e as demais nos tempos seis, 24, 72 h e 15 dias após a inoculação. Este extrato protéico serviu de fonte para as determinações do teor de proteínas solúveis totais (PST), atividade da polifenol oxidase (PPO) e da peroxidase (PO), as quais foram realizadas por leituras espectrofotométricas. Os resultados demonstraram aumento significativo no teor de PST e na atividade de PPO nas plantas submetidas ao tratamento com isolado DFs842, sendo que, o teor de PST foi o dobro, em relação às plantas não tratadas. Também foi observado que, mesmo antes da inoculação do patógeno o teor de PST e a atividade de PPO nas plantas tratadas estavam bem maiores. Em relação à atividade de PO houve redução da mesma nas plantas tratadas com o isolado de Pseudomonas (DFs842). Esses resultados evidenciaram que a microbiolização das sementes provocou alterações metabólicas nas plantas delas originadas, pelo aumento do teor de PST e atividade de PPO, indicando uma provável participação destas enzimas na indução de resistência ativada pela microbiolização com o isolado de Pseudomonas (DFs842).

Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting

We studied the effect of oral sirolimus, administered to prevent and treat in-stent restenosis (ISR), on the variation of serum levels of inflammatory markers following coronary stenting with bare metal stents. The mean age of the patients was 56 ± 13 years, 65% were males and all had clinically manifested ischemia. Serum levels of high sensitivity C-reactive protein (hs-CRP) concentration were determined by chemiluminescence and serum levels of all other biomarkers by ELISA. One group of patients at high risk for ISR received a loading oral dose of 15 mg sirolimus and 5 mg daily thereafter for 28 days after stenting (SIR-G). A control group (CONT-G) was submitted to stenting without sirolimus therapy. The increase in hs-CRP concentration was highest at 24 h after stenting in both groups. A significant difference between SIR-G and CONT-G was observed at 4 weeks (-1.50 ± 5.0 vs -0.19 ± 0.4, P = 0.008) and lost significance 1 month after sirolimus discontinuation (-1.73 ± 4.3 vs -0.01 ± 0.7, P = 0.0975). A continuous fall in MMP-9 concentration was observed in SIR-G, with the greatest reduction at 4 weeks (-352.9 ± 455 vs +395.2 ± 377, P = 0.0004), while a positive variation was noted 4 weeks after sirolimus discontinuation (227 ± 708 vs 406.2 ± 472.1, P = 0.0958). SIR-G exhibited a higher increase in P-selectin after sirolimus discontinuation at week 8 (46.1 ± 67.9 vs 5.8 ± 23.7, P = 0.0025). These findings suggest that the anti-restenotic actions of systemic sirolimus include anti-proliferative effects and modulation of the inflammatory response with inhibition of adhesion molecule expression.